Publication

Idelalisib exposure before allogeneic stem cell transplantation in patients with follicular lymphoma: an EBMT survey

European Society for Blood and Marrow Transplantation Lymphoma and Chronic Malignancies Working Parties, Sellner, L., Schetelig, J., Koster, L., Choi, G., Blaise, D., Beelen, D., Schianca, F. C., Passweg, J., Schanz, U., Gyan, E., Sora, F., Kröger, N., Wulf, G. G., Van Gorkom, G., Mayer, J., Orvain, C., Bourhis, J. H., Jindra, P., Potter, V., Zallio, F., Vandenberghe, E., Robinson, S., Hayden, P. J., Yakoub-Agha, I., Montoto, S. & Dreger, P., 22-May-2020, In : Bone marrow transplantation. 4 p.

Research output: Contribution to journalLetterAcademicpeer-review

Copy link to clipboard

Documents

  • Idelalisib exposure before allogeneic stem cell transplantation in

    Final publisher's version, 614 KB, PDF document

    Request copy

DOI

  • European Society for Blood and Marrow Transplantation Lymphoma and Chronic Malignancies Working Parties
  • Leopold Sellner
  • Johannes Schetelig
  • Linda Koster
  • Goda Choi
  • Didier Blaise
  • Dietrich Beelen
  • Fabrizio Carnevale Schianca
  • Jakob Passweg
  • Urs Schanz
  • Emmanuel Gyan
  • Federica Sora
  • Nicolaus Kröger
  • Gerald G Wulf
  • Gwendolyn Van Gorkom
  • Jiri Mayer
  • Corentin Orvain
  • Jean Henri Bourhis
  • Pavel Jindra
  • Victoria Potter
  • Francesco Zallio
  • Elisabeth Vandenberghe
  • Stephen Robinson
  • Patrick J Hayden
  • Ibrahim Yakoub-Agha
  • Silvia Montoto
  • Peter Dreger
Original languageEnglish
Number of pages4
JournalBone marrow transplantation
Early online date2020
Publication statusPublished - 22-May-2020

    Keywords

  • RITUXIMAB, INHIBITION, OUTCOMES, TRIAL

ID: 126612407